$109+ Billion Global In-vitro Diagnostics Market Analysis to 2029: Rising Acceptance of Fully Automated and Point-of-Care Instruments is Driving Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Nov 3, 2022--

The "In-vitro Diagnostics Market Analysis by Product & Service, by Technology, by Application, End user and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

The in-vitro diagnostics market size is estimated to be USD 109.5 billion in 2021 and is expected to witness a CAGR of 5.73% during the forecast period 2022-2029.

Companies Mentioned

• Roche Diagnostics (Switzerland)
• Siemens Healthineers (Germany)
• Danaher Corporation (US)
• Abbott (US)
• Thermo Fisher Scientific (US). Other players in this market are Johnson & Johnson (US)
• Becton
• Dickinson and Company (US)
• Bio-Rad Laboratories (US)
• Sysmex Corporation (Japan)
• bioMerieux (France)
• DiaSorin (Italy)
• Ortho Clinical Diagnostics (US)
• QIAGEN N.V. (Netherlands)

The increasing geriatric population and the higher margins in the incidence of chronic and infectious diseases, rising acceptance of fully automated and point-of-care instruments in developed regions, growing awareness of disease diagnosis in developing regions, and escalating R&D investments by market players to launch the new IVD products expected to contribute the market growth.

However, unfavourable reimbursement scenario is expected to restrain the market growth.

Market Segmentation:

Product & Service (Revenue, USD Billion)

• Data Management Software
• Reagents & Kits
• Instruments
• Services

By Technology (Revenue, USD Billion)

• Coagulation & Haemostasis
• Molecular Diagnostics
• Clinical Chemistry
• Urinalysis
• Microbiology
• Immunoassay
• Haematology
• Others

By Application (Revenue, USD Billion)

• Autoimmune Diseases
• Infectious Diseases
• Cardiology
• Oncology
• Nephrology
• Autoimmune Diseases
• Drug Testing

By End user (Revenue, USD Billion)

• Clinical Laboratories
• Point-of-care Testing Centres
• Academic Institutes
• Hospital Laboratories
• Patients
• Others

By Region (Revenue, USD Billion)

North America

• U.S
• Canada

Europe

• Germany
• France
• UK
• Spain
• Italy
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Rest of APAC

Latin America

• Brazil
• Mexico
• Argentina
• Rest of LATAM

Middle East & Africa

• South Africa
• GCC
• Rest of MEA

For more information about this report visit https://www.researchandmarkets.com/r/v89lxx

View source version on businesswire.com:https://www.businesswire.com/news/home/20221103005824/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2022.